arbutus
participate
virtual
fireside
chat
chardan
annual
genetic
medicines
conference
warminster
globe
newswire
arbutus
biopharma
corporation
nasdaq
abus
biopharmaceutical
company
primarily
focused
developing
cure
people
chronic
hepatitis
b
virus
hbv
infection
well
therapies
treat
coronaviruses
including
today
announced
company
participate
virtual
fireside
chat
chardan
annual
genetic
medicines
conference
monday
october
pm
et
arbutus
fireside
chat
presenters
william
collier
president
ceo
michael
sofia
chief
scientific
officer
gaston
picchio
chief
development
officer
david
hastings
chief
financial
officer
live
webcast
virtual
fireside
chat
accessed
investors
section
arbutus
website
directly
live
webcast
archived
replay
webcast
available
company
website
conference
arbutus
arbutus
biopharma
corporation
publicly
traded
nasdaq
abus
biopharmaceutical
company
dedicated
discovering
developing
commercializing
cure
people
chronic
hepatitis
b
virus
hbv
infection
company
advancing
multiple
drug
product
candidates
may
combined
potentially
curative
regimen
chronic
hbv
infection
arbutus
also
initiated
drug
discovery
development
effort
treating
coronaviruses
including
information
visit
contact
information
investors
media
william
collier
president
ceo
phone
email
ir
pam
murphy
investor
relations
consultant
phone
email
ir
